Viewing Study NCT02264067


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-05 @ 12:31 AM
Study NCT ID: NCT02264067
Status: COMPLETED
Last Update Posted: 2014-10-15
First Post: 2014-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1998-07
Start Date Type: None
Primary Completion Date: 1998-11
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2014-10-13
First Submit QC Date: None
Study First Post Date: 2014-10-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-13
Last Update Post Date: 2014-10-15
Last Update Post Date Type: ESTIMATED